Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Bonde

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Journal of Medical Virology|August 4, 2025
Clinical Validation of the Venus HPV Full-Genotyping Assay for Cervical Cancer Screening in the VALGENT-4 FrameworkLan Xu, Chang Ma, Kate Cuschieri, et al.
Journal of Clinical Microbiology|June 17, 2016
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningDitte Ejegod, Fabio Bottari, Helle Pedersen, et al.
Plos One|January 21, 2016
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and AboveMatejka Rebolj, Jesper Bonde, Sarah Preisler, et al.
Plos One|April 14, 2016
Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening ProgrammeEspen Enerly, Jesper Bonde, Kristina Schee, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2015
A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30yearsMatejka Rebolj, Jesper Bonde, Ditte Ejegod, et al.
Expert Review of Molecular Diagnostics|May 1, 2019
Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studiesLan Xu, Ina Benoy, Kate Cuschieri, et al.
Journal of Clinical Microbiology|August 19, 2016
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial AssaysMatejka Rebolj, Jesper Bonde, Sarah Preisler, et al.
BMC Clinical Pathology|August 22, 2017
Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type XStefan Haraldsson, Louise Klarskov, Mef Nilbert, et al.
Preventive Medicine|May 20, 2022
Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attendersDitte Møller Ejegod, Helle Pedersen, Birgitte Tønnes Pedersen, et al.
Papillomavirus Research (Amsterdam, Netherlands)|April 25, 2018
Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screeningDitte Møller Ejegod, Helle Pedersen, Garazi Peña Alzua, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Journal of Medical Virology|August 4, 2025
Clinical Validation of the Venus HPV Full-Genotyping Assay for Cervical Cancer Screening in the VALGENT-4 FrameworkLan Xu, Chang Ma, Kate Cuschieri, et al.
Journal of Clinical Microbiology|June 17, 2016
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningDitte Ejegod, Fabio Bottari, Helle Pedersen, et al.
Plos One|January 21, 2016
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and AboveMatejka Rebolj, Jesper Bonde, Sarah Preisler, et al.
Plos One|April 14, 2016
Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening ProgrammeEspen Enerly, Jesper Bonde, Kristina Schee, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2015
A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30yearsMatejka Rebolj, Jesper Bonde, Ditte Ejegod, et al.
Expert Review of Molecular Diagnostics|May 1, 2019
Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studiesLan Xu, Ina Benoy, Kate Cuschieri, et al.
Journal of Clinical Microbiology|August 19, 2016
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial AssaysMatejka Rebolj, Jesper Bonde, Sarah Preisler, et al.
BMC Clinical Pathology|August 22, 2017
Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type XStefan Haraldsson, Louise Klarskov, Mef Nilbert, et al.
Preventive Medicine|May 20, 2022
Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attendersDitte Møller Ejegod, Helle Pedersen, Birgitte Tønnes Pedersen, et al.
Papillomavirus Research (Amsterdam, Netherlands)|April 25, 2018
Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screeningDitte Møller Ejegod, Helle Pedersen, Garazi Peña Alzua, et al.
Pageof 9